US · Healthcare · Medical Devices
EPS came in at 0.51 against a street estimate of 0.52 — a miss of 1.9%.
Analysts rate Iradimed Co a buy (2 buy, 1 hold, 0 sell out of 3) with an average price target of $118.00.
| Fund | Stake |
|---|---|
| BlackRock Inc | 7.57% |
| Kayne Anderson Rudnick Investment Management LLC | 3.10% |
| Renaissance Technologies Corp | 3.08% |
| Copeland Capital Management, LLC | 2.99% |
| Vanguard Capital Management, LLC | 2.85% |
| T. Rowe Price Investment Management,Inc. | 2.49% |
| Geode Capital Management, LLC | 2.27% |
| Nine Ten Capital Management LLC | 2.01% |
| Document | Date |
|---|---|
| Quarterly report · Q3 2026 HEADLINE NUMBERS • Third-quarter 2026 revenue was $24,203, up from $21,202 in Q3 2025. • Nine-month 2026 revenue was $66,648, up from $61,122 in the | 2026-10-30 |
| Results announced · Q4 2026 HEADLINE NUMBERS • Third-quarter 2026 revenue was $24.2 million, up $3.0 million, or 14%, from $21.2 million in third-quarter 2025, and up 18% from t | 2026-10-30 |
| Quarterly report · Q2 2026 IRADIMED CORPORATION – Q2 2026 10-Q SUMMARY HEADLINE NUMBERS • Revenue (6 months): $42,444 thousand (vs. $39,920 thousand in 2025) – up 6.3% • Reven | 2026-07-31 |
| Company announcement · Q3 2026 IRADIMED CORPORATION - FORM 8-K SUMMARY HEADLINE NUMBERS • Company: IRADIMED CORPORATION (Ticker: IRMD, NASDAQ) • Report Date: July 31, 2026 for qua | 2026-07-31 |
| Shareholder vote results · Q2 2026 IRADIMED CORPORATION - FORM 8-K SUMMARY HEADLINE NUMBERS • Annual Stockholder Meeting held June 23, 2026 • Total votes cast for board directors: app | 2026-06-24 |
| Quarterly report · Q1 2026 IRADIMED CORPORATION – Q1 2026 10-Q SUMMARY HEADLINE NUMBERS • Revenue Q1 2026: $21.979 million vs. $19.511 million in Q1 2025 (+12.6% year-over-yea | 2026-05-01 |
| Results announced · Q2 2026 IRADIMED CORPORATION - Q1 2026 FINANCIAL SUMMARY HEADLINE NUMBERS • Q1 2026 Revenue: $22.0 million, up $2.5 million or 13% versus Q1 2025 ($19.5 mil | 2026-05-01 |
| Proxy statement · Q2 2026 IRADIMED CORPORATION PROXY SUMMARY WHAT SHAREHOLDERS ARE VOTING ON • Proposal 1 - Election of Five Directors: Vote to elect Roger Susi (President, C | 2026-04-30 |
Readable in the app.
| Action | Detail | Date |
|---|---|---|
| Dividend | $0.20 / share ex-date Nov 13, 2026 · pay Nov 27, 2026 | 2026-11-13 |
| Dividend | $0.20 / share ex-date Aug 14, 2026 · pay Aug 28, 2026 | 2026-08-14 |
| Dividend | $0.20 / share ex-date May 15, 2026 · pay May 29, 2026 | 2026-05-15 |
| Dividend | $0.20 / share ex-date Feb 23, 2026 · pay Mar 6, 2026 | 2026-02-23 |
| Dividend | $0.50 / share ex-date Dec 17, 2025 · pay Dec 30, 2025 | 2025-12-17 |
| Dividend | $0.17 / share ex-date Nov 14, 2025 · pay Nov 25, 2025 | 2025-11-14 |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Iradimed Co — free to start.
Open in the appGoogle PlayApp StoreData updated 2026-11-07.